Mr. Alex Miller reports

AURORA COMPLETES MAJOR EXPANSION OF EUROPEAN EU-GMP MANUFACTURING FACILITY, MORE THAN DOUBLING EXPECTED ANNUAL FLOWER OUTPUT

Aurora Cannabis Inc. has completed a major expansion of its facility in Leuna, Germany. The expansion project establishes the Leuna facility as a manufacturing site of excellence, incorporating proven cultivation and postharvest practices from Aurora's Canadian operations alongside the company's proprietary genetics and product catalogue. The expanded facility has increased cultivation capacity while improving product quality, consistency and operational efficiency, strengthening the facility's role in serving Aurora's growth in Europe.

To commemorate the site's transformation and expanded role in Aurora's global European Union good manufacturing practice manufacturing network, the facility has been renamed Aurora Horizon, a name selected by the local team, reflective of its pride and optimism for the facility's future.

"The completion of our Leuna facility transformation is an important milestone for Aurora and reinforces our commitment to serving patients in our fastest-growing markets, including Germany, where we are proud to be a domestic manufacturer," said Alex Miller, executive vice-president, operations and supply chain, at Aurora. "Now known as Aurora Horizon, the EU GMP-licensed facility strengthens our ability to serve patients in Germany while advancing our broader European growth strategy. By bringing Aurora's proven cultivation and operational expertise and industry-leading genetics to Leuna, we have significantly advanced the site and our ability to drive growth in the region."

The expanded facility has recently been granted an expanded EU GMP licence for the newly built areas of the site, issued by the State Office for Social Affairs, Youth and Health of Saxony-Anhalt, and will support dynamic job creation within the local vicinity.

The transformation of Aurora Horizon involved implementing the company's world-class cultivation practices and methodologies, including lighting, irrigation, harvesting and postharvest processes, to ensure consistent and high-quality output. Aurora Horizon has adopted Aurora's leading proprietary genetics from the company's global research and development facility, Aurora Coast, in British Columbia, Canada. As a result, the facility is already meeting the high performance thresholds of other sites within Aurora's network. The additional capacity is expected to help Aurora meet growing demand for high-quality medical cannabis in Germany and across European markets while improving supply chain resilience and operational efficiency. As one of only three in country producers, it is uniquely positioned to continue to contribute with cultivation and manufacturing job creation in the Saxony-Anhalt region.

About Aurora Cannabis Inc.

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Drift, San Raf, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Corp., as well as international brands Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, with a focus on high-quality cannabis products, Aurora has brands that continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

Aurora's common shares trade on Nasdaq and the Toronto Stock Exchange under the symbol ACB.

We seek Safe Harbor.